Literature DB >> 1981737

Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine.

A E Cribb1, S P Spielberg.   

Abstract

Sulfonamides are oxidized to protein reactive cytotoxic metabolites by murine hepatic microsomes. Mononuclear leukocytes from patients with idiosyncratic reactions to sulfonamides were more susceptible to toxicity from these metabolites than were leukocytes from a control population, suggesting that these metabolites play a role in the pathogenesis of such reactions. Here we have shown that murine hepatic microsomes oxidize sulfamethoxazole at the N4-position to form the hydroxylamine. Formation of the hydroxylamine was dependent on the presence of microsomes, NADPH, and oxygen. The addition of SKF 525-A, cimetidine, or gassing with carbon monoxide inhibited formation. The enzymic activity was stable at 37 degrees C in the absence of NADPH. Ascorbic acid, N-acetylcysteine, and reduced glutathione significantly increased the yield of hydroxylamine, presumably by decreasing further oxidation and covalent binding. Microsomes prepared from mice treated with phenobarbital or beta-naphthoflavone catalyzed the formation of the hydroxylamine more readily than did microsomes from untreated mice. These results demonstrate that cytochrome P-450-mediated oxidation of sulfamethoxazole results in the formation of hydroxylamines, which can be further oxidized to more reactive intermediates. These metabolites are likely involved in the pathogenesis of idiosyncratic reactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981737

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  7 in total

1.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; C Burkhart; A E Cribb; W J Pichler; B K Park
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  N-acetyltransferases: pharmacogenetics and clinical consequences of polymorphic drug metabolism.

Authors:  S P Spielberg
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

Review 3.  Mechanisms of unpredictable adverse drug reactions.

Authors:  M J Rieder
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

4.  Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.

Authors:  Sachin Bhusari; Mahmoud Abouraya; Marcia L Padilla; Marie E Pinkerton; Nicholas J Drescher; James C Sacco; Lauren A Trepanier
Journal:  Arch Toxicol       Date:  2010-03-11       Impact factor: 5.153

5.  Safety of celecoxib in individuals allergic to sulfonamide: a pilot study.

Authors:  Lori E Shapiro; Sandra R Knowles; Elizabeth Weber; Manuela G Neuman; Neil H Shear
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.

Authors:  David J Feola; Beth A Garvy
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 7.  Allergic adverse reactions to sulfonamides.

Authors:  Geneviève Choquet-Kastylevsky; Thierry Vial; Jacques Descotes
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.